Stocks
Allogene Therapeutics (ALLO) Net debt US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Net debt, bln rub | -384.2 | -416.2 | -353.6 | -201.7 | -167.0 | -185.8 | |||
| Changes by years, y/y, % | -50% | +8% | -15% | -43% | -17% | -26.4% | |||
Allogene Therapeutics. Net debt, bln rub
Allogene Therapeutics. Net debt, changes, %
Allogene Therapeutics (ALLO) Net debt US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Net debt, bln rub | -198.8 | -193.9 | -167.1 | -167.0 | -185.8 | -185.8 | ||
| Changes by years, y/y, % | -31% | -45% | -19% | -17% | -6% | |||
| Changes by quarters, q/q, % | -1% | -2% | -14% | 0% | +11% | |||
